ARS Pharmaceuticals: A Significant Upside Is Expected From neffy (NASDAQ:SPRY)
This article was written byFollow"Fundamental Options" would be the title of my investing style, because I combine fundamental analysis with...
This article was written byFollow"Fundamental Options" would be the title of my investing style, because I combine fundamental analysis with...
FollowPlay Earnings CallPlay Earnings CallArrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Cantor Global Healthcare Conference 2025 September 4, 2025 9:10 AM EDT Company...
This article was written byFollowFounder of Bern Factor LLC, an independent research and publishing firm located in Virginia. I have...
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) 46th Annual Goldman Sachs Global Healthcare Conference June 9, 2025 10:40 AM ET Company Participants Christopher...
Pgiam/iStock via Getty ImagesTarsus Pharma (NASDAQ:TARS) has an approved drug for a mite infestation eye disease called Demodex blepharitis and...